Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Congestive Heart Failure (CHF) Treatment Devices Market Size(US$)
CAGR 2024-2030
3.1%
Market Size,2030
USD 6,369.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 5,303.3 million
Market Forecast in 2030(Value)
US$ 6,369.4 million
CAGR
3.1%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5303.3 million in 2024 to US$ 6369.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Congestive Heart Failure (CHF) Treatment Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Congestive Heart Failure (CHF) Treatment Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Congestive Heart Failure (CHF) Treatment Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Congestive Heart Failure (CHF) Treatment Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Congestive Heart Failure (CHF) Treatment Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Congestive Heart Failure (CHF) Treatment Devices sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
- Abiomed
- Berlin Heart GmbH
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- HeartWare International
- Jarvik Heart
- LivaNova PLC
- Medtronic
- ReliantHeart
- Abbott
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cardiac Resynchronization Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICDs)
Segment by Application
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BIVAD)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Congestive Heart Failure (CHF) Treatment Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Congestive Heart Failure (CHF) Treatment Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Congestive Heart Failure (CHF) Treatment Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
1.2 Market by Type
1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cardiac Resynchronization Therapy (CRT)
1.2.3 Implantable Cardioverter Defibrillators (ICDs)
1.3 Market by Application
1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Left Ventricular Assist Device (LVAD)
1.3.3 Right Ventricular Assist Device (RVAD)
1.3.4 Biventricular Assist Device (BIVAD)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Estimates and Forecasts 2019-2030
2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region
2.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2019-2024)
2.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2025-2030)
2.2.4 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2019-2030)
2.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Estimates and Forecasts 2019-2030
2.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region
2.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2019-2024)
2.4.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2025-2030)
2.4.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers
3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2019-2024)
3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Congestive Heart Failure (CHF) Treatment Devices in 2023
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2019-2024)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2023
3.3 Global Key Players of Congestive Heart Failure (CHF) Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Congestive Heart Failure (CHF) Treatment Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Offered and Application
3.8 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Sales by Type (2019-2024)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Sales by Type (2025-2030)
4.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Revenue by Type (2019-2024)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Revenue by Type (2025-2030)
4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type
4.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2019-2024)
4.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application
5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Sales by Application (2019-2024)
5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Sales by Application (2025-2030)
5.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application
5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Historical Revenue by Application (2019-2024)
5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecasted Revenue by Application (2025-2030)
5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
5.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application
5.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2019-2024)
5.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
6.1.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2030)
6.1.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2030)
6.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
6.2.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2030)
6.2.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2030)
6.3 US & Canada Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
6.3.1 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
6.3.3 US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
7.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2030)
7.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2030)
7.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
7.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2030)
7.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2030)
7.3 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Country
7.3.1 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
7.3.3 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Congestive Heart Failure (CHF) Treatment Devices Market Size
8.1.1 China Congestive Heart Failure (CHF) Treatment Devices Sales (2019-2030)
8.1.2 China Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030)
8.2 China Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
8.2.1 China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2030)
8.2.2 China Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
9.1.1 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2030)
9.1.2 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2030)
9.2 Asia Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
9.2.1 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2030)
9.2.2 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2030)
9.3 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region
9.3.1 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2019-2030)
9.3.3 Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abiomed
11.1.1 Abiomed Company Information
11.1.2 Abiomed Overview
11.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abiomed Recent Developments
11.2 Berlin Heart GmbH
11.2.1 Berlin Heart GmbH Company Information
11.2.2 Berlin Heart GmbH Overview
11.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Berlin Heart GmbH Recent Developments
11.3 Biotronik SE & Co. KG
11.3.1 Biotronik SE & Co. KG Company Information
11.3.2 Biotronik SE & Co. KG Overview
11.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotronik SE & Co. KG Recent Developments
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Information
11.4.2 Boston Scientific Corporation Overview
11.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boston Scientific Corporation Recent Developments
11.5 HeartWare International
11.5.1 HeartWare International Company Information
11.5.2 HeartWare International Overview
11.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HeartWare International Recent Developments
11.6 Jarvik Heart
11.6.1 Jarvik Heart Company Information
11.6.2 Jarvik Heart Overview
11.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jarvik Heart Recent Developments
11.7 LivaNova PLC
11.7.1 LivaNova PLC Company Information
11.7.2 LivaNova PLC Overview
11.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 LivaNova PLC Recent Developments
11.8 Medtronic
11.8.1 Medtronic Company Information
11.8.2 Medtronic Overview
11.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medtronic Recent Developments
11.9 ReliantHeart
11.9.1 ReliantHeart Company Information
11.9.2 ReliantHeart Overview
11.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ReliantHeart Recent Developments
11.10 Abbott
11.10.1 Abbott Company Information
11.10.2 Abbott Overview
11.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Congestive Heart Failure (CHF) Treatment Devices Industry Chain Analysis
12.2 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Congestive Heart Failure (CHF) Treatment Devices Production Mode & Process
12.4 Congestive Heart Failure (CHF) Treatment Devices Sales and Marketing
12.4.1 Congestive Heart Failure (CHF) Treatment Devices Sales Channels
12.4.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
12.5 Congestive Heart Failure (CHF) Treatment Devices Customers
13 Market Dynamics
13.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends
13.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers
13.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges
13.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints
14 Key Findings in The Global Congestive Heart Failure (CHF) Treatment Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Cardiac Resynchronization Therapy (CRT)
Table 3. Major Manufacturers of Implantable Cardioverter Defibrillators (ICDs)
Table 4. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2019-2024)
Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2025-2030)
Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2025-2030) & (K Units)
Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2019-2024)
Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2025-2030)
Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers (2019-2024)
Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Congestive Heart Failure (CHF) Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2023)
Table 23. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Offered and Application
Table 25. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024) & (K Units)
Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030) & (K Units)
Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2019-2024)
Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2025-2030)
Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2019-2024)
Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2025-2030)
Table 35. Congestive Heart Failure (CHF) Treatment Devices Price by Type (2019-2024) & (USD/Unit)
Table 36. Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030) & (K Units)
Table 39. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2019-2024)
Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2025-2030)
Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2019-2024)
Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2025-2030)
Table 45. Congestive Heart Failure (CHF) Treatment Devices Price by Application (2019-2024) & (USD/Unit)
Table 46. Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2025-2030) & (USD/Unit)
Table 47. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 60. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024) & (K Units)
Table 61. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030) & (K Units)
Table 62. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 65. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030) & (K Units)
Table 66. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 72. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 73. China Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024) & (K Units)
Table 74. China Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030) & (K Units)
Table 75. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 78. China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030) & (K Units)
Table 79. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024) & (K Units)
Table 82. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030) & (K Units)
Table 83. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 86. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030) & (K Units)
Table 87. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 93. Asia Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 107. Abiomed Company Information
Table 108. Abiomed Description and Major Businesses
Table 109. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Abiomed Recent Developments
Table 112. Berlin Heart GmbH Company Information
Table 113. Berlin Heart GmbH Description and Major Businesses
Table 114. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Berlin Heart GmbH Recent Developments
Table 117. Biotronik SE & Co. KG Company Information
Table 118. Biotronik SE & Co. KG Description and Major Businesses
Table 119. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biotronik SE & Co. KG Recent Developments
Table 122. Boston Scientific Corporation Company Information
Table 123. Boston Scientific Corporation Description and Major Businesses
Table 124. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boston Scientific Corporation Recent Developments
Table 127. HeartWare International Company Information
Table 128. HeartWare International Description and Major Businesses
Table 129. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. HeartWare International Recent Developments
Table 132. Jarvik Heart Company Information
Table 133. Jarvik Heart Description and Major Businesses
Table 134. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Jarvik Heart Recent Developments
Table 137. LivaNova PLC Company Information
Table 138. LivaNova PLC Description and Major Businesses
Table 139. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. LivaNova PLC Recent Developments
Table 142. Medtronic Company Information
Table 143. Medtronic Description and Major Businesses
Table 144. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Medtronic Recent Developments
Table 147. ReliantHeart Company Information
Table 148. ReliantHeart Description and Major Businesses
Table 149. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. ReliantHeart Recent Developments
Table 152. Abbott Company Information
Table 153. Abbott Description and Major Businesses
Table 154. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Abbott Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 160. Congestive Heart Failure (CHF) Treatment Devices Customers List
Table 161. Congestive Heart Failure (CHF) Treatment Devices Market Trends
Table 162. Congestive Heart Failure (CHF) Treatment Devices Market Drivers
Table 163. Congestive Heart Failure (CHF) Treatment Devices Market Challenges
Table 164. Congestive Heart Failure (CHF) Treatment Devices Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Type in 2023 & 2030
Figure 4. Cardiac Resynchronization Therapy (CRT) Product Picture
Figure 5. Implantable Cardioverter Defibrillators (ICDs) Product Picture
Figure 6. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Application in 2023 & 2030
Figure 8. Left Ventricular Assist Device (LVAD)
Figure 9. Right Ventricular Assist Device (RVAD)
Figure 10. Biventricular Assist Device (BIVAD)
Figure 11. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2019-2030 (US$ Million)
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2019-2030)
Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2019-2030 ((K Units)
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2019-2030) & (K Units)
Figure 23. China Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Congestive Heart Failure (CHF) Treatment Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Congestive Heart Failure (CHF) Treatment Devices in the World: Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2023
Figure 30. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
Figure 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
Figure 33. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
Figure 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Country (2019-2030)
Figure 40. US & Canada Congestive Heart Failure (CHF) Treatment Devices Sales Share by Country (2019-2030)
Figure 41. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
Figure 44. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
Figure 45. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
Figure 46. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
Figure 47. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Country (2019-2030)
Figure 48. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Share by Country (2019-2030)
Figure 49. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 50. France Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 54. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
Figure 55. China Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
Figure 56. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
Figure 57. China Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
Figure 58. Asia Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
Figure 59. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
Figure 60. Asia Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
Figure 61. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
Figure 62. Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Region (2019-2030)
Figure 63. Asia Congestive Heart Failure (CHF) Treatment Devices Sales Share by Region (2019-2030)
Figure 64. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 68. India Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Share by Country (2019-2030)
Figure 75. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Revenue (2019-2030) & (US$ Million)
Figure 80. Congestive Heart Failure (CHF) Treatment Devices Value Chain
Figure 81. Congestive Heart Failure (CHF) Treatment Devices Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Related Reports
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-16
Pages: 94
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-24
Pages: 123
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-02-25
Pages: 86
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 110
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 132
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 115
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 135
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-16
Pages: 94
USD 2900.00 (Single User License)Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-24
Pages: 123
USD 3950.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-02-25
Pages: 86
USD 2900.00 (Single User License)Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 110
USD 3950.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 132
USD 4900.00 (Single User License)Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 115
USD 2900.00 (Single User License)Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 135
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research